The drug works by blocking two important metabolic pathways that
the leukemia cells need to grow and spread.
Not exact matches
«Ultimately, we
needed 20 years to learn how to supercharge these
cells to deliver anticancer activity,» says Arie Belldegrun, president and CEO of Kite Pharma in Santa Monica, California, which is assessing CAR T
cells in six trials for B
cell leukemia and lymphomas, and glioblastoma.
Likewise, the American Medical Association endorses donations to a public bank, unless there's a known medical reason a family member might
need the umbilical cord
cells, such as a
leukemia diagnosis for an older child.
He
needed a stem
cell transplant, which is a normal treatment for
leukemia, but his cancer
needed to be in remission first, and the chemotherapy wasn't working.
«Further research is
needed to characterize how we can potentially remove or block this protein to stop the proliferation of
leukemia cells.»
He noted that before physicians and scientists begin offering SSC transplantation in patients, additional research will be
needed, including whether other types of
leukemia cells will also be eliminated in the
cell - propagation process.
After cancer chemotherapy failed, Brown
needed a stem
cell transplant for his
leukemia.
The approach, which is described in a paper to be published September 7 in The Journal of Experimental Medicine, could allow those in
need of such transplants, including
leukemia and lymphoma patients, to be treated with fewer donor stem
cells while limiting potential adverse side effects.
Scientists developing new
cell therapy methods for the treatment of disorders such as sickle
cell disease or
leukemia need to consider how their culture conditions may affect the success of their translational research.
However, recent studies suggest that the threshold of T
cell responses
needed to eradicate
leukemia cells is different from the responses threshold required for mediating GVHD.
St. Jude Children's Research Hospital investigators report that measuring
leukemia cells that persist in patient bone marrow in the early weeks of treatment helps identify high - risk patients who
need intensive therapy.
While leaving the West Coast appointment, she got a call from DeZern informing her that the most recent tests indicated Cavalancia also had some
leukemia cells in her blood that
needed to be treated right away.
Canine
leukemia can be
cell - specific, but the bottom line is that it is cancer and
needs to be treated as such.